Gr. Sarantis S.A. (SRTSF)
USD 11.15
(0.0%)
USD 11.15
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 66.92 Million EUR | 39.78% |
| 2022 | 41.06 Million USD | -10.37% |
| 2021 | 51.58 Million USD | -12.97% |
| 2020 | 61.43 Million USD | 30.86% |
| 2019 | 46.84 Million USD | 12.41% |
| 2018 | 46.99 Million EUR | 19.27% |
| 2017 | 39.65 Million EUR | 36.3% |
| 2016 | 35.91 Million EUR | 7.15% |
| 2015 | 23.92 Million EUR | -6.87% |
| 2014 | 25.68 Million EUR | 11.98% |
| 2013 | 22.94 Million EUR | 8.38% |
| 2012 | 21.16 Million EUR | 7.84% |
| 2011 | 19.62 Million EUR | -7.94% |
| 2010 | 21.32 Million EUR | -21.12% |
| 2009 | 27.02 Million EUR | -27.95% |
| 2008 | 37.51 Million EUR | 52.35% |
| 2007 | 24.62 Million EUR | -26.36% |
| 2006 | 33.43 Million EUR | 15.75% |
| 2005 | 28.88 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 44.13 Million USD | 0.0% |
| 2023 Q1 | 14.17 Million EUR | -41.46% |
| 2023 Q3 | 15.97 Million EUR | -48.48% |
| 2023 FY | - USD | 39.78% |
| 2023 Q2 | 31 Million USD | 118.83% |
| 2023 Q4 | 35.47 Million USD | 122.0% |
| 2022 Q4 | 24.2 Million USD | 167.24% |
| 2022 Q3 | 9.05 Million EUR | -23.4% |
| 2022 FY | - USD | -10.37% |
| 2022 Q2 | 11.82 Million USD | -5.3% |
| 2022 Q1 | 12.48 Million EUR | 19.39% |
| 2021 Q3 | 10.64 Million EUR | -28.14% |
| 2021 FY | - USD | -12.97% |
| 2021 Q1 | 14.64 Million EUR | 2.08% |
| 2021 Q2 | 14.81 Million USD | 1.16% |
| 2021 Q4 | 10.45 Million USD | -1.73% |
| 2020 Q3 | 13.76 Million EUR | 5.22% |
| 2020 Q4 | 14.34 Million USD | 4.18% |
| 2020 FY | - USD | 30.86% |
| 2020 Q1 | 12.83 Million EUR | 27.24% |
| 2020 Q2 | 13.08 Million USD | 1.97% |
| 2019 Q2 | 11.96 Million USD | 1.38% |
| 2019 Q3 | 9.8 Million EUR | -18.06% |
| 2019 FY | - USD | 12.41% |
| 2019 Q1 | 11.79 Million EUR | -29.25% |
| 2019 Q4 | 10.08 Million USD | 2.91% |
| 2018 Q3 | 16.9 Million EUR | 61.91% |
| 2018 FY | - EUR | 19.27% |
| 2018 Q4 | 16.67 Million EUR | -1.32% |
| 2018 Q1 | 11.01 Million EUR | -22.58% |
| 2018 Q2 | 10.43 Million EUR | -5.21% |
| 2017 Q1 | 8.5 Million EUR | -23.12% |
| 2017 FY | - EUR | 36.3% |
| 2017 Q4 | 14.22 Million EUR | 1.51% |
| 2017 Q3 | 14.01 Million EUR | 53.82% |
| 2017 Q2 | 9.1 Million EUR | 7.06% |
| 2016 Q2 | 8.26 Million EUR | -2.49% |
| 2016 Q3 | 11.81 Million EUR | 42.9% |
| 2016 Q1 | 8.47 Million EUR | -24.86% |
| 2016 FY | - EUR | 7.15% |
| 2016 Q4 | 11.06 Million EUR | -6.3% |
| 2015 Q1 | 3.67 Million EUR | -64.25% |
| 2015 Q4 | 11.28 Million EUR | 24.82% |
| 2015 Q3 | 9.03 Million EUR | 56.56% |
| 2015 Q2 | 5.77 Million EUR | 57.07% |
| 2015 FY | - EUR | -6.87% |
| 2014 FY | - EUR | 11.98% |
| 2014 Q1 | 3.06 Million EUR | -59.74% |
| 2014 Q2 | 5.61 Million EUR | 82.94% |
| 2014 Q4 | 10.27 Million EUR | 53.85% |
| 2014 Q3 | 6.68 Million EUR | 19.0% |
| 2013 Q1 | 3.43 Million EUR | -61.14% |
| 2013 FY | - EUR | 8.38% |
| 2013 Q4 | 7.62 Million EUR | 19.22% |
| 2013 Q3 | 6.39 Million EUR | 15.81% |
| 2013 Q2 | 5.52 Million EUR | 60.86% |
| 2012 Q1 | 2.69 Million EUR | -63.26% |
| 2012 Q4 | 8.83 Million EUR | 49.1% |
| 2012 FY | - EUR | 7.84% |
| 2012 Q3 | 5.92 Million EUR | 59.48% |
| 2012 Q2 | 3.71 Million EUR | 37.89% |
| 2011 FY | - EUR | -7.94% |
| 2011 Q1 | 3.01 Million EUR | -67.84% |
| 2011 Q2 | 3.85 Million EUR | 27.7% |
| 2011 Q3 | 5.41 Million EUR | 40.53% |
| 2011 Q4 | 7.33 Million EUR | 35.32% |
| 2010 FY | - EUR | -21.12% |
| 2010 Q4 | 9.39 Million EUR | 526.65% |
| 2010 Q3 | 1.49 Million EUR | -73.65% |
| 2010 Q2 | 5.68 Million EUR | 20.85% |
| 2010 Q1 | 4.7 Million EUR | -43.15% |
| 2009 Q1 | 3.57 Million EUR | 0.0% |
| 2009 Q3 | 6.08 Million EUR | -33.55% |
| 2009 FY | - EUR | -27.95% |
| 2009 Q4 | 8.27 Million EUR | 36.12% |
| 2009 Q2 | 9.15 Million EUR | 156.17% |
| 2008 FY | - EUR | 52.35% |
| 2007 FY | - EUR | -26.36% |
| 2006 FY | - EUR | 15.75% |
| 2005 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -77.49 Thousand USD | 86462.932% |
| Bruush Oral Care Inc. | -4.9 Million USD | 1463.93% |
| CCA Industries, Inc. | -259.14 Thousand USD | 25924.697% |
| DSwiss, Inc. | 20 Thousand USD | -334479.722% |
| EOS, Inc. | -592.2 Thousand USD | 11400.662% |
| Greyson International, Inc. | -75.91 Thousand USD | 88260.501% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -55668.863% |
| Infusion Brands International, Inc. | -6.17 Million USD | 1183.27% |
| Mandom Corporation | 44.26 Million USD | -51.202% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -597.89 Thousand USD | 11293.06% |
| Oliveda International, Inc. | -1.18 Million USD | 5732.569% |
| PacificHealth Laboratories, Inc. | -430 Thousand USD | 15663.331% |
| Prosperous Future Holdings Limited | -19.68 Million USD | 439.95% |
| PURE Bioscience, Inc. | -3.04 Million USD | 2296.345% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -476.51 Thousand USD | 14144.065% |
| Sentient Brands Holdings Inc. | -246.98 Thousand USD | 27196.269% |
| Sunset Capital Assets, Inc. | -190.12 Thousand USD | 35298.912% |
| The Stephan Co. | -124 Thousand USD | 54069.868% |
| Turner Valley Oil & Gas, Inc. | -115.2 Thousand USD | 58188.532% |
| Winning Brands Corporation | -267.95 Thousand USD | 25075.792% |
| Warpaint London PLC | 26.02 Million USD | -157.108% |
| Zoono Group Limited | -5.41 Million USD | 1336.308% |
| Zurvita Holdings, Inc. | -79.68 Thousand USD | 84085.036% |